PURPOSE OF REVIEW: Chagas cardiomyopathy is a major public health disease in Latin America and, due to migration, is becoming a worldwide health and economic burden. This review sought to present the clinical and epidemiological aspects of Chagas cardiomyopathy, as well as some specific features and principles of treatment. We also retrospectively assessed our institutional experience with mechanical circulatory support in refractory heart failure due to Chagas cardiomyopathy over a 10-year period. RECENT FINDINGS: The role of antiparasitic treatment in patients with heart failure due to Chagas cardiomyopathy is controversial. Heart transplantation, although formerly contraindicated, is currently established as an important therapeutic option. Also, the favorable characteristics of Chagas patients, such as younger age, little comorbidity, and no reoperations or severe pulmonary hypertension, could be an advantage for a mechanical circulatory support indication in advanced heart failure due to Chagas cardiomyopathy. Despite the absence of large evidence-based data, much has been accomplished since Carlos Chagas' discovery one century ago. Our institutional experience shows that mechanical circulatory support in Chagas patients is associated with more successful bridging to heart transplantation when compared to non-Chagas patients.
PURPOSE OF REVIEW: Chagas cardiomyopathy is a major public health disease in Latin America and, due to migration, is becoming a worldwide health and economic burden. This review sought to present the clinical and epidemiological aspects of Chagas cardiomyopathy, as well as some specific features and principles of treatment. We also retrospectively assessed our institutional experience with mechanical circulatory support in refractory heart failure due to Chagas cardiomyopathy over a 10-year period. RECENT FINDINGS: The role of antiparasitic treatment in patients with heart failure due to Chagas cardiomyopathy is controversial. Heart transplantation, although formerly contraindicated, is currently established as an important therapeutic option. Also, the favorable characteristics of Chagas patients, such as younger age, little comorbidity, and no reoperations or severe pulmonary hypertension, could be an advantage for a mechanical circulatory support indication in advanced heart failure due to Chagas cardiomyopathy. Despite the absence of large evidence-based data, much has been accomplished since Carlos Chagas' discovery one century ago. Our institutional experience shows that mechanical circulatory support in Chagas patients is associated with more successful bridging to heart transplantation when compared to non-Chagas patients.
Authors: Luiz Felipe P Moreira; João Galantier; Anderson Benício; Adolfo A Leirner; Idágene A Cestari; Noedir A G Stolf Journal: Artif Organs Date: 2007-04 Impact factor: 3.094
Authors: Carlos A Morillo; Hetty Waskin; Sergio Sosa-Estani; Maria Del Carmen Bangher; Carlos Cuneo; Rodolfo Milesi; Marcelo Mallagray; Werner Apt; Juan Beloscar; Joaquim Gascon; Israel Molina; Luis E Echeverria; Hugo Colombo; Jose Antonio Perez-Molina; Fernando Wyss; Brandi Meeks; Laura R Bonilla; Peggy Gao; Bo Wei; Michael McCarthy; Salim Yusuf Journal: J Am Coll Cardiol Date: 2017-02-28 Impact factor: 24.094
Authors: Carlos A Morillo; Jose Antonio Marin-Neto; Alvaro Avezum; Sergio Sosa-Estani; Anis Rassi; Fernando Rosas; Erick Villena; Roberto Quiroz; Rina Bonilla; Constança Britto; Felipe Guhl; Elsa Velazquez; Laura Bonilla; Brandi Meeks; Purnima Rao-Melacini; Janice Pogue; Antonio Mattos; Janis Lazdins; Anis Rassi; Stuart J Connolly; Salim Yusuf Journal: N Engl J Med Date: 2015-09-01 Impact factor: 91.245
Authors: Jefferson L Vieira; Maria G V Sobral; Francisco Y Macedo; Raquel S Florêncio; Germana P L Almeida; Glauber G Vasconcelos; Juliana R Fernandes; Laura L E Marinho; Daniel F M Trompieri; Tilak K R Pasala; Juan A C Mejia; João D Souza-Neto Journal: Transplant Direct Date: 2022-06-24
Authors: Baljinder Singh; Jean A Bernatchez; Laura-Isobel McCall; Claudia M Calvet; Jasmin Ackermann; Julia M Souza; Diane Thomas; Everton M Silva; Kelly A Bachovchin; Dana M Klug; Hitesh B Jalani; Seema Bag; Melissa J Buskes; Susan E Leed; Norma E Roncal; Erica C Penn; Jessey Erath; Ana Rodriguez; Richard J Sciotti; Robert F Campbell; James McKerrow; Jair L Siqueira-Neto; Lori Ferrins; Michael P Pollastri Journal: ACS Med Chem Lett Date: 2020-01-10 Impact factor: 4.345
Authors: Orlando G Elso; Augusto E Bivona; Andrés Sanchez Alberti; Natacha Cerny; Lucas Fabian; Celina Morales; César A N Catalán; Emilio L Malchiodi; Silvia I Cazorla; Valeria P Sülsen Journal: Molecules Date: 2020-04-25 Impact factor: 4.411
Authors: Thiago R Morais; Geanne A Alves Conserva; Marina T Varela; Thais A Costa-Silva; Fernanda Thevenard; Vitor Ponci; Ana Fortuna; Amílcar C Falcão; Andre G Tempone; João Paulo S Fernandes; João Henrique G Lago Journal: Sci Rep Date: 2020-03-25 Impact factor: 4.379